In vitro and in vivo evaluation of a whole blood platelet-sparing leukoreduction filtration system

Transfusion

Volumn 50, Issue 10, 2010, Pages 2145-2151

  Snyder, Edward L ^a,b,c,d   Kingsbury, Pamela Whitley ^a,b,c   Kingsbury, Tracy ^a,b,c   Miripol, Jeffrey ^a,b,c   Tormey, Christopher A ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Terumo Medical Corporation   (United States)

^d YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; INDIUM 111; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD DONOR; BLOOD FILTRATION; BLOOD SAMPLING; BLOOD STORAGE; ERYTHROCYTE COUNT; HEMOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LEUKAPHERESIS; LEUKOCYTE COUNT;

BLOOD DONORS; BLOOD PRESERVATION; ERYTHROCYTES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; LEUKOCYTES; PLASMA; PLATELET TRANSFUSION;

EID: 78649482158     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02701.x     Document Type: Article

References (20)

1. Dzik W. Leukoreduction of blood components. Curr Opin Hematol 2002;9:521-6.
2. Blajchman M. The clinical benefits of the leukoreduction of blood products. J Trauma 2006;60(Suppl):S83-90.
3. Heddle N. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 1999;6: 420-6.
4. Sakagawa H, Miyazaki T, Fujihara M, Sato S, Yamaguchi M, Fukai K, Morioka M, Kato T, Azuma H, Ikeda H. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Transfusion 2007;47:154-61.
5. Slichter S. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
6. Roback J, Su L, Zimring JC, Hillyer CD. Transfusiontransmitted cytomegalovirus: lessons from a murine model. Transfus Med Rev 2007;21:26-36.
7. Stramer S. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007;131:702-7.
8. Bowden R, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusionassociated CMV infection after marrow transplant. Blood 1995;86:3598-603.
9. Nielsen HJ, Hammer JH, Krarup AL, Nielsen LM, Reimert CM, Pedersen AN, Dybkjaer E, Partoft S, Alsbjørn B. Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns 1999;25:162-70.
10. Larsson S, Gulliksson H, Paunovic D. Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies. Transfusion 2001;41:534-9.
11. Dzik WH, Szuflad P. Method for counting white cells in white-cell reduced red cell concentrates. Transfusion 1993; 33:272.
12. Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, Stromberg RR for the BEST (Biomedical Excellence for Safer Transfusion) Task Force of the ISBT. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994;8:29-36.
13. Ebaugh FG, Emerson CP, Ross JF. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination of red cell survival in vivo. J Clin Invest 1953;32: 1260-76.
14. AuBuchon JP. Radioisotopic reflections. Transfusion 2005;45 Suppl:28S-32S.
15. The Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Platelet radiolabeling procedure. Transfusion 2006;46:59S-66S.
16. Paglino J, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16-24.
17. Tormey CA, Sweeney JD, Champion MH, Pisciotto PT, Snyder EL, Wu Y. Analysis of transfusion reactions associated with prestorage-pooled platelet components. Transfusion 2009;49:1242-7.
18. Buchholz D, AuBuchon JP, Snyder EL, Kandler R, Edberg S, Piscitelli V, Pickard C, Napychank P. Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion 1992;32:667-72.
19. Siblini L, Lafeuillade B, Ros A, Le Petit JC, Pozzetto B. Reduction of Yersinia enterocolitica load in deliberately inoculated blood: the effects of blood prestorage temperature and WBC filtration. Transfusion 2002;42:422-7.
20. Cardo L, Salata J, Harman R, Mendez J, Weina PJ. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside. Transfusion 2006;46:896-902.